We used murine Aclyflox/flox hepatocellular carcinoma (HCC) cell lines and generated isogenic cell lines lacking ACLY or ACSS2 via adenoviral Cre treatment or CRISPR-Cas9 gene editing, respectively (fig. This evidence concerns the gene ACLY and hepatocellular carcinoma.